Outpatient Worsening Heart Failure in an Integrated Health Care Delivery System: An Innovative Approach to Characterizing a Novel Clinical Entity
Outpatient Worsening Heart Failure in an Integrated Health Care Delivery System: An Innovative Approach to Characterizing a Novel Clinical Entity
批准号:
10685420
负责人:
Andrew Patrick Ambrosy
金额:
$19.21万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-08-01 至 2025-07-31
关键词:
AcuteAddressAffordable Care ActAlgorithmsAwardBoard CertificationCaliforniaCardiacCaringCharacteristicsClinicalClinical TrialsComputer softwareCongestive Heart FailureDataData SourcesDevicesDiseaseEHR researchEnvironmentEpidemiologyEventFundingFutureGoalsGuidelinesHealth PolicyHealth ServicesHealth systemHeart failureHospitalizationHospitalsImpairmentIncentivesIncidenceInstitutionIntegrated Delivery of Health CareInternationalK-Series Research Career ProgramsKnowledgeLearningLocationMachine LearningManualsMedicalMentorsMentorshipMethodologyMorbidity - disease rateNatural HistoryNatural Language ProcessingOutcomeOutpatientsPatient AdmissionPatient CarePatientsPharmaceutical PreparationsPhysiciansPragmatic clinical trialPublic HealthRecommendationRecording of previous eventsReportingResearchResearch MethodologyResearch PersonnelResearch Project GrantsResearch ProposalsResourcesRiskRisk AdjustmentScienceScientistSeriesSystemTrainingUnited States National Institutes of HealthWorkadjudicationanalytical methodclinical encounterclinical riskcohortdeep learningdesignelectronic health record systemevidence baseexperiencehealth related quality of lifehigh riskhospital readmissionimplementation scienceimprovedinnovationinterestmachine learning algorithmmortalitynovelprogramsprospectivereadmission ratesskillsstandard of caresuccesstreatment patterntrendunstructured data
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Although the management of ambulatory heart failure (HF) has been revolutionized by evidence-based drug
and device therapies, there has been no such parallel progress in the care of patients admitted for worsening
HF (WHF). To incentivize health systems to reduce 30-day readmissions, the Affordable Care Act (ACA)
launched the Hospital Readmission Reduction Program (HRRP) in 2012, which penalizes hospitals financially
if they have higher than expected risk-adjusted 30-day readmission rates for conditions including HF. Although
the HRRP has modestly reduced readmissions, this program has had the unintended consequence of shifting
a significant fraction of HF-related care to the outpatient setting. Thus, there is a growing interest in the field to
disentangle WHF from location of care and move away from using hospitalization as a surrogate for acute
decompensated HF. However, little is known about the epidemiology, clinical profile, treatment patterns, and/or
outcomes of outpatient WHF. In addition, while the overall survival of ambulatory HF patients has improved
dramatically, guideline-directed medical therapy (GDMT) has had minimal impact on impairments in health-
related quality of life (HRQOL). Despite this reality, there are few real-world data sources available to describe
the trajectory of HRQOL in the ambulatory setting. To address these critical knowledge gaps, we propose (1)
to systematically describe the contemporary epidemiology, clinical characteristics, treatment patterns, and
outcomes associated with outpatient WHF and (2) to evaluate the impact of an episode of outpatient WHF on
generic and disease-specific HRQOL in the context of a fully integrated health care delivery system. The first
objective will leverage observational data from a large, state-of-the-art, and validated electronic health record
(EHR) system and machine learning algorithms for natural language processing (NLP) to systematically
ascertain and comprehensively characterize episodes of outpatient WHF. The second objective will
prospectively apply this software-based solution to evaluate generic and disease-specific HRQOL among
patients with a recent clinical encounter for outpatient WHF. The overarching goal of this career development
award is to provide me with the requisite training in research methodology and project experience to build upon
my past successes as a traditional clinical trialist in order to also becoming a leader in health services,
implementation science, and pragmatic clinical trials within a learning health system. Strengths of my
proposal include my prior relevant training and track record in research, the experience and commitment of my
mentors, collaborators, and consultants, and the vast institutional resources and support. In summary, this
research proposal will employ innovative analytic approaches to elucidate the epidemiology, clinical features,
and outcomes of this previously underappreciated and novel clinical entity. Given the current trend towards
managing acute cardiac conditions primarily in the ambulatory setting, these findings have immediate
implications for formulating public health policy as well as the design and conduct of future clinical trials.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/s12265-021-10151-7
发表时间:
2022-03
期刊:
Journal of cardiovascular translational research
影响因子:
3.4
作者:
[Morrill J, Qirko K, Kelly J, Ambrosy A, Toro B, Smith T, Wysham N, Fudim M, Swaminathan S]
通讯作者:
Swaminathan S
DOI:
10.1016/j.isci.2021.103040
发表时间:
2021-09-24
期刊:
iScience
影响因子:
5.8
作者:
[Kosmopoulos A, Bhatt DL, Meglis G, Verma R, Pan Y, Quan A, Teoh H, Verma M, Jiao L, Wang R, Juliano RA, Kajil M, Kosiborod MN, Bari B, Berih AA, Aguilar M, Escano A, Leung A, Coelho I, Hibino M, Díaz R, Mason RP, Steg PG, Simon T, Go AS, Ambrosy AP, Choi R, Kushner AM, Leiter LA, Al-Omran M, Verma S, Mazer CD]
通讯作者:
Mazer CD
DOI:
10.1002/ehf2.13823
发表时间:
2022-04
期刊:
ESC heart failure
影响因子:
3.8
作者:
[Salah HM, Minhas AMK, Khan MS, Khan SU, Ambrosy AP, Blumer V, Vaduganathan M, Greene SJ, Pandey A, Fudim M]
通讯作者:
Fudim M
DOI:
10.1007/s11883-022-01032-8
发表时间:
2022-07
期刊:
CURRENT ATHEROSCLEROSIS REPORTS
影响因子:
5.8
作者:
[Tobler, Diana L., Pruzansky, Alix J., Naderi, Sahar, Ambrosy, Andrew P., Slade, Justin J.]
通讯作者:
Slade, Justin J.
Acetazolamide as a decongestion strategy in acute decompensated heart failure: Balancing fluid removal and electrolyte disturbances.
乙酰唑胺作为急性失代偿性心力衰竭的减充血策略:平衡液体清除和电解质紊乱。
DOI:
10.1002/ejhf.2935
发表时间:
2023
期刊:
European journal of heart failure
影响因子:
18.2
作者:
[Butte,Zara, Ambrosy,AndrewP]
通讯作者:
Ambrosy,AndrewP
共 14 条
Outpatient Worsening Heart Failure in an Integrated Health Care Delivery System: An Innovative Approach to Characterizing a Novel Clinical Entity
-
批准号:10222774
-
项目类别:
-
资助金额:$19.21万
-
财政年份:2020
-
负责人:Andrew Patrick Ambrosy
-
依托单位:
Outpatient Worsening Heart Failure in an Integrated Health Care Delivery System: An Innovative Approach to Characterizing a Novel Clinical Entity
-
批准号:10475613
-
项目类别:
-
资助金额:$19.21万
-
财政年份:2020
-
负责人:Andrew Patrick Ambrosy
-
依托单位:
Outpatient Worsening Heart Failure in an Integrated Health Care Delivery System: An Innovative Approach to Characterizing a Novel Clinical Entity
-
批准号:10054615
-
项目类别:
-
资助金额:$19.21万
-
财政年份:2020
-
负责人:Andrew Patrick Ambrosy
-
依托单位:
海外基金